Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04657185 · ClinicalTrials.gov registry record
Reducing Perioperative S. Aureus Transmission Via OR PathTrac
A clinical trial of Surgical Site Infection and S. Aureus Transmission, sponsored by Georgetown University.
- Completed
- Registry status
- 804
- Enrollment target
- 1
- Study location
NCT04657185: Completed study of Surgical Site Infection and S. Aureus Transmission, sponsored by Georgetown University.
NCT04657185 is a study of Surgical Site Infection and S. Aureus Transmission that has completed, run by Georgetown University. The registered enrollment target is 804 participants, above the 536-participant average among 25 other Surgical Site Infection trials with a reported enrollment target (50% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04657185, a study of Surgical Site Infection and S. Aureus Transmission, has completed, sponsored by Georgetown University.
- COMPLETED
- Registry status
- 804 participants
- Enrollment target
- 1
- Study location
Study Summary
Healthcare-associated infections (HAIs) occur frequently and are associated with patient harm. It is important that healthcare facilities take the necessary steps to prevent the spread of resistant bacteria. ESKAPE bacteria (Enterococcus, S. aureus, Klebsiella, Acinetobacter, Pseudomonas, and Enterobacter spp.) are particularly pathogenic. Isolation of these pathogens from intraoperative reservoirs has been associated with postoperative infection development (i.e. surgical site infections). This project involves implementation of a software platform and bacterial collection system (OR PathTrac) that leverages the epidemiology of intraoperative bacterial transmission to guide dynamic, prospective improvements in perioperative infection control measures. The investigators will assess the effectiveness of OR PathTrac feedback in optimizing an evidence-based, multifaceted, perioperative infection control program.
Primary Outcome
S. aureus transmission events detected within a surgical case
Conditions Studied
Interventions
- OTHER OR PathTrac Feedback Optimization
Study Locations (1)
District of Columbia
- Georgetown University - Georgetown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 804 participants |
| Start Date | 2019-07-15 |
| Est. Completion | 2020-03-20 |
What the finished NCT04657185 record still lists
NCT04657185 is an observational study that tracks outcomes without assigning an intervention. The registered 804 participants enrollment target is mid-sized for trials with a published cap, above the 536-participant average among 25 other Surgical Site Infection trials with a reported enrollment target (50% higher).
The record links to 2 conditions, with Surgical Site Infection appearing as the primary indexed condition, and to 1 intervention - of which OR PathTrac Feedback Optimization is the first listed.
NCT04657185 reports a single indexed study location in District of Columbia.
Frequently Asked Questions
What is clinical trial NCT04657185 about?
NCT04657185 is a clinical study titled "Reducing Perioperative S. Aureus Transmission Via OR PathTrac". Healthcare-associated infections (HAIs) occur frequently and are associated with patient harm. It is important that healthcare facilities take the necessary steps to prevent the spread of resistant bacteria. ESKAPE bacteria (Enterococcus, S. aureus, Klebsiella, Acinetobacter, Pseudomonas, and Entero...
What is the current status of trial NCT04657185?
This trial is currently completed. The enrollment target is 804 participants. The study started on 2019-07-15. Estimated completion is 2020-03-20.
What conditions does trial NCT04657185 study?
This clinical trial studies the following conditions: Surgical Site Infection, S. Aureus Transmission.
What interventions are being tested in trial NCT04657185?
The interventions under investigation include: OR PathTrac Feedback Optimization (OTHER).
Who is sponsoring clinical trial NCT04657185?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04657185 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Surgical Site Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04657185's enrollment target sits among peer trials
804 6th of 25 higher than 20 of 25 other Surgical Site Infection trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Surgical Site Infection trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Zinc Oxide Versus Petrolatum Following Skin Surgery
RECRUITING · Early Phase 1
-
Diluted Aqueous Povidone-Iodine Compared to Saline to Decrease Surgical Site Infections
RECRUITING · Phase 3
-
Decolonization to Reduce After-Surgery Events of Surgical Site Infection
RECRUITING · Phase 4
-
Studying How Outpatient Water affEcts Risks With Drains (SHOWER Study)
RECRUITING · NA
-
A Novel Surgical Irrigation Solution in Post-Mastectomy Reconstruction: Evaluating Xperience™
RECRUITING · NA
-
Ostomy Primary Closure With 0.1% Betaine/Polyhexanide Wound Irrigation Compared to Pursestring Closure
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04423211 · 804 participants · Phase 3
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- NCT06522022 · 804 participants · NA
PTSD Screening in Pregnant Black Women
- NCT04613596 · 806 participants · Phase 2
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
- NCT06065098 · 806 participants · NA
Church-based Health Intervention to Eliminate Racial Inequalities in Cardiovascular Health
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI